Coronary Artery Calcium Score: A Tool for Stratifying Cardiac Risk

This is a short review of the clinical utility of the coronary calcium score, particularly focused on the low-to-medium risk patient who is uncertain about the risks and benefits of more intensive preventive therapy (e.g., HMG-CoA reductase inhibitors, aspirin, blood pressure-lowering drugs). The technology for determining a coronary calcium score is now more widely available, and has been proven to correlate with intracoronary stenoses, and to be a strong predictor of all-cause mortality. The discussion will center around two illustrative cases in which the coronary calcium score was quite helpful.

Dr. Welch has no actual or potential conflict of interest in relation to this program or presentation.

The Washington Osteopathic Medical Association is accredited by the American Osteopathic Association as a Category 1 CME Sponsor. 
The WOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements.
Comments, questions, or complaints should be forwarded to WOMA Executive Director, Roseanne Andersen, by calling the WOMA office at 425-677-3930, by mail to WOMA, P.O. Box 1187, Gig Harbor, WA 98332, or by email to executivedirector@woma.org.